Annual General Shareholders’ Meeting 2023 – June 16, 2023 - 2nd call – Expected to be held on this date / June 15, 2023 - 1st call. Click here.

Company
Innovation
Sustainability
Products and services
Investors
Careers
Media
Partners
Contact

Company

Since 1909, Grifols has worked to improve the health and well-being of people around the world.

What we do
Mission and values
Ethics and compliance

Grifols Engineering

Our history
Grifols museum
Grifology
- The Cabinet

Every action we take is motivated by our mission to improve people's lives.

Our unique and remarkable history combines scientiﬁc expertise with a desire to serve patients and society.

We develop, produce and market innovative medicines, solutions and services in more than 110 countries.

Innovation

Grifols is full speed ahead on developing the next innovative breakthroughs across multiple therapeutic areas.

Plasma Powerhouse
Beyond plasma
Key therapeutic areas

Extending our innovative reach
- Team up with Grifols Innovation and New Technologies
- Scientific Awards and Programs
Connecting knowledge - Our R&D network

We apply our growing knowledge of plasma to change healthcare.

Our treatments are enhancing people’s well-being and quality of life.

We’re drawing on a broad scientific base to continue innovating.

Sustainability

Grifols' longstanding commitment to people and the planet entails helping society on all fronts.

Commitment to donors and patients
- Supporting donors
- Supporting patients
Impact on society
Our people

The environment
Ethical leadership

Sustainability Reports

2022 Sustainability Report: a detailed overview of our sustainability strategy, actions and progress

Read

Patients drive the work we do every day. We support patients and patient associations.

Learn more

As mindful stewards of the environment we are resolved to fight climate change.

Investors

Stock information
Financials

Press releases
Presentations and events
Agenda
Communications with regulators (CNMV/SEC)
Corporate Stewardship Reports

Corporate governance
Mergers
Biotest: voluntary takeover offer |
Freiwilliges übernahmeangebot

Here you can read our Q1 2023 financial results

Read results

Please click here to listen to the webcast of our Q1 2023 financial results

Listen to the webcast

The 2022 Integrated and Sustainability Annual Report is now available

Careers

People are at the heart of our business. We are committed to continued investment in training and development.

Training and development

Media

Latest news about the company and contact information for journalists and communication professionals.

Media contacts

Newsroom

Media Center

Contact

International Headquarters

Adverse reactions – Pharmacovigilance

Grifols Ethics Helpline

Show menu

com.grifols.labels.close-menu

Company Innovation Sustainability Products and services Investors Careers Media Partners Contact

English

Spanish
German
Chinese

Back

Company What we do Mission and values Ethics and compliance Grifols Engineering Our history Grifols museum Grifology

English

Spanish
German
Chinese

Back

What we do Biopharma Diagnostic Bio Supplies Healthcare Solutions for Hospitals

English

Spanish
German
Chinese

Back

Mission and values

English

Spanish
German
Chinese

Back

Ethics and compliance

English

Spanish
German
Chinese

Back

Grifols Engineering Engineering Machinery Consulting Contact

English

Spanish
German
Chinese

Back

Our history

English

Spanish
German
Chinese

Back

Grifols museum La Casa: where it all began The Plant: people helping people The World: From family business to global company

English

Spanish
German
Chinese

Back

Grifology The Cabinet

English

Spanish
German
Chinese

Back

Innovation Plasma Powerhouse Beyond plasma Key therapeutic areas Extending our innovative reach Connecting knowledge - Our R&D network

English

Spanish
German
Chinese

Back

Plasma Powerhouse

English

Spanish
German
Chinese

Back

Beyond plasma

English

Spanish
German
Chinese

Back

Key therapeutic areas Immunology Hepatology and Intensive Care Pulmonology Hematology Neurology Infectious Diseases Further Therapeutic Opportunities

English

Spanish
German
Chinese

Back

Extending our innovative reach Team up with Grifols Innovation and New Technologies Scientific Awards and Programs

English

Spanish
German
Chinese

Back

Connecting knowledge - Our R&D network

English

Spanish
German
Chinese

Back

Sustainability Commitment to donors and patients Impact on society Our people The environment Ethical leadership Sustainability Reports

English

Spanish
German
Chinese

Back

Commitment to donors and patients Supporting donors Supporting patients

English

Spanish
German
Chinese

Back

Impact on society

English

Spanish
German
Chinese

Back

Our people

English

Spanish
German
Chinese

Back

The environment

English

Spanish
German
Chinese

Back

Ethical leadership

English

Spanish
German
Chinese

Back

Sustainability Reports

English

Spanish
German
Chinese

Back

Products and services

English

Spanish
German
Chinese

Back

Investors Stock information Financials Press releases Presentations and events Agenda Communications with regulators (CNMV/SEC) Corporate Stewardship Reports Corporate governance Mergers Biotest: voluntary takeover offer |
Freiwilliges übernahmeangebot

English

Spanish
German
Chinese

Back

Stock information Stock and share capital Dividends Major holders and treasury stock Agreements between shareholders Analyst coverage

English

Spanish
German
Chinese

Back

Financials Financial results Annual accounts Fixed income and credit ratings Average period of payment to suppliers

English

Spanish
German
Chinese

Back

Press releases

English

Spanish
German
Chinese

Back

Presentations and events

English

Spanish
German
Chinese

Back

Agenda

English

Spanish
German
Chinese

Back

Communications with regulators (CNMV/SEC) CNMV SEC Other relevant information Inside information Relevant events up to Dec. 31^st, 2019

English

Spanish
German
Chinese

Back

Corporate Stewardship Reports

English

Spanish
German
Chinese

Back

Corporate governance Board of Directors General Shareholders’ Meeting Annual corporate governance report Directors' remuneration report Articles of association Corporate policies

English

Spanish
German
Chinese

Back

Mergers

English

Spanish
German
Chinese

Back

Biotest: voluntary takeover offer |
Freiwilliges übernahmeangebot

English

Spanish
German
Chinese

Back

Careers Training and development

English

Spanish
German
Chinese

Back

Training and development

English

Spanish
German
Chinese

Back

Media Media contacts Newsroom Media Center

English

Spanish
German
Chinese

Back

Media contacts

English

Spanish
German
Chinese

Back

Newsroom

English

Spanish
German
Chinese

Back

Media Center

English

Spanish
German
Chinese

Back

Partners

English

Spanish
German
Chinese

Back

Contact International Headquarters Adverse reactions – Pharmacovigilance Grifols Ethics Helpline

English

Spanish
German
Chinese

Back

International Headquarters

English

Spanish
German
Chinese

Back

Adverse reactions – Pharmacovigilance

English

Spanish
German
Chinese

Back

Grifols Ethics Helpline

English

Spanish
German
Chinese

INVESTORS

Investor Unsuscribe

UNSUBSCRIBE

*Required fields.

The information contained on the Grifols worldwide website is not applicable to all countries. For specific information on the products and services available in your country, please select your country from the list included in the corresponding section. The purpose of this website is to provide information about Grifols' products and services, and it is not intended for, nor may it be construed to, promoting any products in countries in which they are not approved.

ABOUT US

TOP WEBSITES

The Grifols Academy of Plasmapheresis

Grifols Scientific Awards

Grifols Engineering

Grifols Egypt for Plasma Derivatives

Victor Grifols i Lucas Foundation

Probitas Foundation

J.A. Grifols Foundation

HELP

This website uses its own and third party essential (to remember your settings) and non-essential (to analyse our traffic) cookies. Further information about our use of cookies and the third parties using them can be found in our Cookies Policy.

You can accept all non-essential cookies by clicking the "Accept" button, reject their use by clicking the "Refuse" button or set your preferencies by clicking the "Settings" link.

You can withdraw or change your cookies consent at any time by visiting our Cookies Policy.

Settings

Refuse Accept

Grifols, S.A.

Avenida de la Generalitat, 152, 08174

Sant Cugat del Vallès (Barcelona), Spain

Essential cookies

These are strictly necessary for the Site to work as requested. Some examples are activating basic functions such as page navigation and access to secure Site areas or customizing the Site presentation (e.g. language). Without these cookies, the Site would not be able to work properly.

Cookies details

By clicking below you consent to the use of the following non-essential cookies:

Analytic cookies

These allow understanding how visitors interact with the Site by monitoring and analyzing your behavior and with the purpose of improving the Site.

Cookies details

Save settings